Clinicians should identify risk factors and not insulin resistance in clinical practice - (13/10/06)
Document Actions
Although insulin resistance is a core component of the metabolic syndrome, there is no clinical benefit in measuring insulin levels and insulin resistance in clinical practice. These measurements should be reserved for large epidemiological studies. Clinicians should rather identify risk factors - fasting glucose, lipid levels, hypertension and central obesity – by using simple and inexpensive techniques such as history-taking, physical examination, and very basic investigations.
